将免疫疗法纳入急性淋巴细胞白血病的前线治疗中
1Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Clinical advances in hematology & oncology : H&O
|September 22, 2025
概括
免疫疗法彻底改变了急性淋巴细胞白血病 (ALL) 的治疗方法,特别是在复发性/耐药性 (R/R) ALL. 新型免疫疗法如双特异性抗体,ADC和CAR T细胞提供了更好的结果,副作用更少.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 在过去的20年里,免疫疗法显著改善了急性淋巴细胞白血病 (ALL) 的治疗结果.
- 这种进展在复发性和耐药性 (R/R) ALL中尤其显著,传统治疗结果很差.
- 已建立的免疫疗法包括单克隆抗体,双特异性抗体,抗体-药物联合体 (ADC) 和仿制抗原受体 (CAR) T 细胞疗法.
研究的目的:
- 审查新的免疫疗法选择,用于初步治疗新诊断的ALL.
- 讨论在初始治疗环境中整合双特异性抗体,ADC和CAR T细胞疗法.
- 为新诊断的ALL患者提供对这些新型药物的最佳使用的见解,单独使用或与化疗结合使用.
主要方法:
- 关于ALL免疫疗法的当前文献的综述.
- 对双特异性抗体,ADC和CAR T细胞疗法的疗效和安全性数据的分析.
- 讨论新诊断和R/R ALL的治疗策略.
主要成果:
- 免疫疗法已经改变了R/R ALL的治疗模式,提供了比化疗更好的结果.
- 新药在R/R和新诊断的ALL环境中都显示出有效性和安全性.
- 与传统化疗相比,这些疗法与较少的长期副作用有关.
结论:
- 免疫疗法代表了ALL治疗的重大进展,特别是R/R疾病.
- 新型免疫疗法越来越多地被纳入新诊断的ALL的预先治疗方案.
- 优化这些药物的使用,在组合或单一治疗中,对于改善患者的治疗结果至关重要.
更多相关视频
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.9K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.7K
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K